hormone replacement therapy Tagged Articles

Wyeth paid ghostwriters to sway doctors to prescribe HRT

Posted: August 6, 2009 Pharmaceutical

Drug maker Wyeth paid ghostwriters to write articles for medical journals that were favorable to the company’s hormone replacement therapy (HRT) Prempro , even after the drug was found to raise a woman’s risk for breast cancer and other serious

Hormone treatment receives black box warning; risk of dementia

Posted: July 15, 2009 Product Liability

“Take comfort in your protection with PROMETRIUM,” reads the tag line on the Web site for a treatment to prevent endometrial hyperplasia in postmenopausal women who still have a uterus and are taking estrogen. But there’s little comfort in the

Study: HRT puts women at greater risk for ovarian cancer

Posted: July 15, 2009 Pharmaceutical

Use of hormone replacement therapy (HRT) among postmenopausal women has been linked to a sharply increased risk of ovarian cancer, according to a study conducted by a team of researchers in Denmark. The study included data from 900,000 Danish women

Greater reduction in HRT/breast cancer rates in urban, affluent towns

Posted: July 8, 2009 Pharmaceutical

A decrease in reported cases of breast cancer across the country linked to the decline of hormone replacement therapy (HRT) is more significant in affluent, urban areas, according to a study published in the journal BMC Medicine.

Judge orders WHI follow-up data be released to Wyeth

Posted: June 29, 2009 Pharmaceutical

U.S. District Judge Bill Wilson Jr. has ordered scientific data collected by the Cancer Research Center since August 2005 as a follow up to a study on the effects of hormone replacement therapy (HRT) on postmenopausal women should be released to

Researchers working on safer synthetic HRT for menopause

Posted: June 27, 2009 Pharmaceutical

Researchers in Ottawa, Canada are hoping to ease women’s fear of hormone replacement drugs by creating and testing synthetic hormones to combat aggravating symptoms of menopause, according to Canada.com. The research follows an earlier grant from the Canadian Breast Cancer

Prempro increases risk of dying from small cell lung cancer

Posted: June 5, 2009 Pharmaceutical

Women who took Wyeth’s hormone replacement therapy (HRT) Prempro at least five years are at greater risk of dying from non-small cell lung cancer, according to a recent study presented at an American Society of Clinical Oncology meeting.

Tamoxifen with antidepressants may raise risk of breast cancer recurrence

Posted: June 4, 2009 Pharmaceutical

The Food and Drug Administration (FDA) is expected to issue a warming to doctors about an increased risk of the recurrence of breast cancer with patients taking both the breast cancer drug tamoxifen and select antidepressants, according to a study

HRT-breast cancer risk same regardless of family history

Posted: May 27, 2009 Pharmaceutical

Women on hormone replacement therapy (HRT) who have no family history of breast cancer have the same risk of developing breast cancer as women with a family history who are on HRT, according to a University of Rochester Medical Center

More studies help women make educated decisions about HRT

Posted: April 27, 2009 Pharmaceutical

The more than 2 million baby-boomer women who are approaching menopause may find themselves in a precarious position when it comes to handling hot flashes and mood swings. Should they risk the threat of breast cancer from use of hormone